Cardiovascular system¶
flowchart LR
z2[Zone 2 training] --> sv[stroke volume ↑]
hiit[HIIT] --> vo2[VO2max ↑]
sv --> rhr[resting HR ↓]
vo2 --> longevity[longevity]
artery[arterial health] --> pwv[PWV ↓]
artery --> bp[BP ↓]
longevity --- pwv
- supplements — omega-3, K2, magnesium — the cardiovascular-relevant stack
- sport & movement — Zone 2 + HIIT protocol
- food as fuel — diet interface with CV risk
- body as engine — cardiovascular as one subsystem of the engine
- health as infrastructure — the four levers — CV sits in all four
- brain-body axis — cerebrovascular disease; HRV as autonomic window
Investigation · rating: high. VO2max data is among the strongest in all of epidemiology. Arterial biology is well-understood. Training response is documented across decades of sport science.
- PreviousCancer
- NextCatastrophic Risks
Status: budding | 2026-05-22 | rating: high Compress levels: L0 ↓ L1 ↓ L2
The heart is not a pump you maintain — it's a pump you train. Everything else follows from how well it moves oxygen.
L0 — TL;DR (≤5 lines)¶
The cardiovascular system is a pump (heart), pressure lines (arteries), and exchange surfaces (capillaries) delivering O₂ and clearing waste at every tissue. Its chief trainable output — VO₂max — is the single strongest predictor of all-cause mortality in any population studied, stronger than smoking, blood pressure, or LDL cholesterol. "Vascular-jacked-but-light" is the distance-runner phenotype: high cardiac stroke volume, low resting HR, clean low-stiffness arteries, high HRV — all reachable at any age by structured aerobic training. Atherosclerosis is inflammatory biology, not just fat in a pipe; it starts in childhood and is influenced most by LDL particle burden, blood pressure, glucose, and inflammation — not cholesterol headlines.
L1 — Overview¶
Core question¶
What does it take to build maximum cardiovascular capacity and minimum arterial disease burden simultaneously — and how do you measure that you're succeeding?
Why it matters¶
- Mandsager 2018 (JAMA, n=122,000): top-decile VO₂max vs. bottom-decile = 5× lower all-cause mortality — larger than any single pharmacological intervention ever measured.
- Every 1 MET increase in exercise capacity ≈ 13% lower mortality risk (Kokkinos 2010; 6,200 veterans, 7-year follow-up).
- Cardiovascular disease kills ~18M people/year globally — the leading cause of death by a wide margin. Most risk is modifiable.
- The system is more plastic than any other organ system: VO₂max can improve 20–40% with training; arterial stiffness reverses with sustained aerobic work; the heart literally remodels its geometry in response to load.
- "Vascular-jacked" is not an aesthetic goal — it is the biological substrate for everything else: energy, cognition, recovery, longevity.
Mermaid map (L1)¶
flowchart TB
heart[Heart — pump] --> aorta[Aorta / arteries — pressure lines]
aorta --> cap[Capillaries — exchange surfaces]
cap --> veins[Veins — return]
veins --> heart
train[Training] -->|stroke volume ↑| heart
train -->|arterial compliance ↑| aorta
train -->|capillarization| cap
risk[Risk: LDL-P, BP, glucose, smoke, inflammation] -->|atherosclerosis| aorta
risk -->|plaque rupture| MI[MI / stroke]
vo2[VO₂max] -.strongest longevity predictor.-> longevity[Longevity]
heart --> vo2
click aorta "../SUPPLEMENTS/" "omega-3, K2 arterial interface"
click train "../SPORT-AND-MOVEMENT/" "Zone 2 + HIIT protocol"
Skeleton sub-claims¶
- VO₂max is the longevity metric. More predictive than smoking status, blood pressure, or lipids across every age and sex group studied. Measured in mL O₂/kg/min; each MET ≈ 3.5 mL/kg/min.
- Stroke volume is the engine. Endurance training grows the left ventricle (eccentric hypertrophy): more volume per beat → lower resting HR → more cardiac reserve. An athlete's resting HR of 42 bpm is not a problem — it is the result.
- Arterial stiffness is independently dangerous. Pulse wave velocity (PWV) predicts CV mortality above and beyond blood pressure. Arteries stiffen with hypertension, hyperglycemia, smoking, and chronic inflammation; Zone 2 training reverses it via the nitric oxide pathway.
- Atherosclerosis is inflammatory, not just lipid accumulation. LDL-P (particle number), not LDL-C (concentration), predicts plaque. CAC score (coronary artery calcium imaging) sees the actual disease burden, not surrogate markers.
- HRV is the daily readout. Heart rate variability tracks autonomic balance: high HRV = higher vagal tone, better recovery capacity, lower sympathetic load. It responds sensitively to sleep, alcohol, overtraining, and illness before symptoms appear.
- Zone 2 + HIIT is the protocol. Zone 2 (~60-70% HRmax) builds mitochondrial density, stroke volume, and arterial compliance. HIIT (4×4 min at 90-95% HRmax) is the fastest route to VO₂max gains. Strength training is cardioprotective but cannot replace aerobic work for VO₂max.
L2 — Deep dive¶
1. The pump — cardiac mechanics¶
The heart outputs: CO = stroke volume × heart rate. Cardiac output at rest ≈ 5 L/min; at VO₂max exercise ≈ 20-25 L/min (untrained) to 35-40 L/min (elite endurance).
| Metric | Untrained adult | Fit amateur | Elite endurance athlete |
|---|---|---|---|
| Resting HR | 60-80 bpm | 50-60 bpm | 28-50 bpm |
| Stroke volume (rest) | 60-80 mL | 90-110 mL | 130-200 mL |
| VO₂max (male) | 35-40 mL/kg/min | 45-55 mL/kg/min | 70-90 mL/kg/min |
| VO₂max (female) | 28-34 mL/kg/min | 38-48 mL/kg/min | 60-75 mL/kg/min |
| Max cardiac output | ~20 L/min | ~25 L/min | ~35-40 L/min |
Eccentric vs concentric hypertrophy: - Endurance training → eccentric hypertrophy: left ventricle dilates, walls stay thin; more volume per beat; the "athlete's heart." - Resistance training → concentric hypertrophy: walls thicken, cavity stays same; better pressure generation, less stroke volume improvement. - Pathological hypertrophy (hypertension, HCM) → concentric with fibrosis; dangerous. Distinguishing athlete's heart from HCM: athlete's HR returns fast; athlete's ECG has typical patterns; athlete's changes reverse with detraining.
2. VO₂max — the metric that matters most¶
VO₂max = maximal oxygen consumption = maximal rate at which the system can extract, deliver, and use O₂. It is bounded by: (a) cardiac output, (b) oxygen-carrying capacity (hemoglobin), and (c) peripheral extraction at muscles.
Mortality data (key studies):
| Study | N | Finding |
|---|---|---|
| Mandsager 2018 (JAMA) | 122,000 | Top vs. bottom VO₂max quintile: 5× all-cause mortality difference |
| Myers 2002 (NEJM) | 6,213 | Each 1 MET increase = 12% lower mortality |
| Kokkinos 2010 (Circulation) | 6,200 | 13% lower mortality per 1 MET; low fitness = higher risk than DM or HTN |
| Blair 1989 (JAMA) | 13,344 | Low CRF predicts death independent of body fat |
VO₂max targets by age (male, percentiles):
| Age | Bottom 25% | Average | Top 25% | Elite amateur |
|---|---|---|---|---|
| 20-29 | <38 | 44 | 52 | >60 |
| 30-39 | <34 | 42 | 49 | >55 |
| 40-49 | <31 | 38 | 46 | >50 |
| 50-59 | <27 | 35 | 42 | >45 |
| 60-69 | <23 | 31 | 38 | >40 |
Natural decline: ~1% per year after 25-30 without training. Training can maintain near-peak into the 50s; athletes in their 60s routinely score what sedentary 30-year-olds score.
Field test (Cooper): run as far as possible in 12 minutes. VO₂max ≈ (distance_m − 504.9) / 44.73.
3. Training protocol — building vascular-jacked¶
Two zones do the work; everything else is recovery:
Zone 2 (fat-max, ~60-70% HRmax, conversational pace): - Builds mitochondrial density, capillarization, stroke volume, arterial compliance. - Minimum dose for cardiac adaptation: ~150 min/week. Strong dose: 3-5 h/week. - Subjective marker: can hold full sentences; nose-breathing is comfortable. - Blood lactate marker: 1.5-2.0 mmol/L (below the aerobic threshold). - Fat-max: the zone where fat oxidation peaks; trains the metabolic engine, not just the cardiovascular pipe.
HIIT — VO₂max intervals (90-95% HRmax): - The fastest route to VO₂max gains in healthy adults. - Standard protocol: 4×4 min at 90-95% HRmax, 3-min active rest, 1-2×/week. - Norwegian method (Helgerud 2007): 4×4 improved VO₂max 7.2% in 8 weeks in moderately fit subjects; more effective than LSD (long slow distance) or threshold work. - Overdose risk: >2× HIIT/week without Zone 2 base → sympathetic dominance, HRV suppression, overtraining syndrome.
Strength training: - Concentric cardiac hypertrophy protects against heart failure (Manson 2002). - Not a VO₂max substitute — even heavy training raises VO₂max <5% without aerobic work. - Role: metabolic buffer (muscle mass), postural support, skeletal protection. - For "vascular-jacked-but-light": keep strength training, but aerobic work is primary.
Steps (NEAT — non-exercise activity thermogenesis): - 15k steps/day ≈ 2h low-intensity activity; measurably lowers CV mortality even in exercisers (Paluch 2021: 9,000-10,500 steps saturates the longevity signal in most adults). - Breaks up sedentary time; restores peripheral circulation.
4. Arterial health — the pipes¶
Arteries are not passive pipes. They are active, contractile, endocrine organs. Endothelial cells produce nitric oxide (NO) in response to shear stress from blood flow; NO relaxes smooth muscle → vasodilation → lower BP. This pathway is the mechanism by which aerobic exercise protects arteries.
Pulse wave velocity (PWV): the speed of the pressure wave through the arterial tree; stiff arteries → faster wave → higher reflected pressure → higher systolic BP. PWV >10 m/s is associated with substantially higher CV risk independent of measured BP.
| Arterial state | PWV | Associated with |
|---|---|---|
| Optimal (young athlete) | <6 m/s | Low CV risk |
| Normal adult | 6-8 m/s | Baseline population risk |
| Stiffened (hypertension/aging) | 8-12 m/s | Elevated CV risk |
| Severely stiffened | >12 m/s | High short-term event risk |
What stiffens arteries: chronic hypertension, hyperglycemia (cross-links collagen via AGEs), smoking, chronic inflammation (CRP > 3 mg/L), low estrogen (post-menopause risk jump), sedentary lifestyle.
What reverses stiffness: sustained aerobic training (PWV improvements observed at 12 weeks Zone 2), BP control, smoking cessation, GLP-1 agonists (in obese/diabetic), dietary nitrates (beet root, leafy greens → NO substrate).
Blood pressure targets: - Normal: <120/80 mmHg - Elevated: 120-129/<80 - Stage 1 HTN: 130-139/80-89 - Stage 2 HTN: ≥140/≥90 - Aerobic exercise alone lowers BP 4-9 mmHg (equivalent to one antihypertensive).
5. Atherosclerosis — inflammatory biology¶
The standard narrative (dietary fat → cholesterol → clogs arteries) is wrong in detail. Correct model: endothelial injury → LDL particles enter subendothelial space → oxidized → macrophages engulf → foam cells → plaque → rupture → thrombosis.
LDL particle number (LDL-P) vs LDL-C: - LDL-C measures the cholesterol content of LDL particles. - LDL-P (or ApoB, a 1:1 proxy) counts the particles. - Risk is driven by particle count (Krauss 2010); same LDL-C can mean 2× different LDL-P. - ApoB is the best single lipid predictor of CV events; increasingly preferred over LDL-C.
Coronary artery calcium (CAC) score: - CT imaging counts calcified plaque in coronary arteries. - CAC = 0 at age 45+ = very low short-term event risk regardless of lipid levels. - CAC > 100 = substantial plaque burden; drives more aggressive management. - The only test that shows the actual disease, not surrogates.
Risk factor table:
| Factor | Mechanism | Magnitude |
|---|---|---|
| LDL-P / ApoB high | Direct particle entry into intima | Dose-dependent; central causal factor |
| Hypertension | Endothelial shear damage; forces LDL entry | Doubles event risk at >140 systolic |
| Smoking | Oxidative stress, endothelial dysfunction, thrombogenicity | 2-4× event risk; reverses ~10y after quitting |
| Hyperglycemia / T2DM | AGE cross-linking, endothelial glycation, dyslipidemia | 2-4× event risk |
| Chronic inflammation (hs-CRP >3) | Accelerates plaque instability | Treated by JUPITER trial: statin → 44% CV event reduction in high-CRP, normal-LDL |
| Low VO₂max | Every pathway: BP, glycemia, LDL, HRV | 2-5× event risk |
| Sedentary behavior (>8h/day) | Independent of exercise sessions | +30-40% CV mortality vs. active matched |
| Low HDL | Reverse cholesterol transport impaired | Protective when genetic; not straightforward to raise pharmacologically |
6. HRV — daily window into the system¶
Heart rate variability = beat-to-beat variation in the RR interval. High HRV indicates the parasympathetic (vagal) system is actively modulating rhythm — a sign of healthy cardiac autonomic control.
Key measurement: RMSSD (root mean square of successive differences) is the standard HRV metric; least sensitive to respiration artifacts; best for short-term morning scans.
| Population | RMSSD (approx) |
|---|---|
| Elite endurance athletes | 80-120 ms |
| Fit active adults | 50-80 ms |
| Average sedentary adult | 25-50 ms |
| Overtrained / ill / alcoholic | <25 ms; suppressed |
What raises HRV: aerobic fitness, adequate sleep, low inflammation, slow breathing (resonance frequency ~5-6 breaths/min), cold exposure.
What suppresses HRV: alcohol (even 1-2 drinks → measurable suppression for 24-48 h), overtraining (sympathetic dominance), illness, sleep deprivation, chronic stress.
How to use it: track morning baseline trend, not single readings. A 3-day suppression is a signal to reduce training load or investigate illness. Rising HRV trend = adaptation to training.
7. The vascular-jacked-but-light phenotype¶
The target state for maximum cardiovascular performance at low body mass:
| Metric | Target | Why |
|---|---|---|
| VO₂max | >50 mL/kg/min (amateur target); >55 elite amateur | Top quintile longevity; requires light body and trained heart |
| Resting HR | <55 bpm | High stroke volume; excellent at 42-50 in serious aerobic athletes |
| HRV (RMSSD) | >60 ms, trending up | Parasympathetic dominance; recovery capacity |
| Blood pressure | <115/75 | Minimal arterial load; maximum endothelial health |
| PWV | <7 m/s | Low arterial stiffness; low reflected pressure |
| ApoB | <70 mg/dL | Low LDL particle burden; below atherosclerosis threshold |
| hs-CRP | <1 mg/L | Low vascular inflammation |
| CAC (at 45+) | 0 | Zero calcified plaque; confirms low arterial disease burden |
| Body weight | Low for height | VO₂max is mL/kg/min — weight is the denominator |
"Light" matters mechanically: VO₂max is weight-normalized. A 90 kg man with excellent absolute O₂ capacity may score the same VO₂max as a 70 kg man with a weaker heart — because the denominator is kilograms. Distance runners and rowers are vascular-jacked-but-light by necessity: every unnecessary kilogram costs VO₂max.
Protocol sketch for the target phenotype: - Zone 2: 3-5 h/week (daily if possible; walking counts partially) - HIIT: 1-2×/week, 4×4 Helgerud protocol - Strength: 2-3×/week, compound movements, low-rep heavy + volume - Steps: 15k/day (already running) - Sleep: 8h (already running) — the HRV and recovery cornerstone - Alcohol: zero; single best overnight HRV intervention available
8. Diet interface¶
| Factor | Mechanism | Direction |
|---|---|---|
| Omega-3 EPA+DHA | TG↓, anti-inflammatory, endothelial function | Protective; 1-4 g/day |
| Dietary nitrates (beets, leafy greens) | NO substrate → vasodilation → BP↓ | Protective; acute effect within hours |
| Saturated fat (myristic, palmitic) | LDL-C and LDL-P↑ via LDL-receptor downregulation | Risk-amplifying at high intake |
| Refined sugar / fructose | TG↑, insulin resistance, endothelial glycation | Risk-amplifying |
| Sodium | BP↑ in salt-sensitive individuals (~50% of hypertensives) | Context-dependent; potassium ratio matters more |
| Potassium (fruit, vegetables) | Counteracts sodium; BP↓ 3-5 mmHg | Protective |
| Mediterranean diet overall | Bundle effect: olive oil, fish, vegetables, nuts | PREDIMED 2013: 30% CV event reduction |
| Alcohol | Mendelian randomization: no benefit; dose-dependent harm | Risk-amplifying; AF trigger; HRV suppressor |
The alcohol note: the "one glass of wine is cardioprotective" narrative comes from observational confounding (light drinkers are healthier in many ways). Mendelian randomization studies (genetic proxy for alcohol consumption) consistently show no benefit and dose-dependent harm starting at the first drink.
9. Measurement battery — what to track and when¶
| Test | Frequency | Why |
|---|---|---|
| Resting HR (morning) | Daily (wearable) | Overtraining, illness early warning |
| HRV (RMSSD, morning) | Daily (wearable) | Training readiness; parasympathetic trend |
| Blood pressure | Monthly or when symptomatic | Arterial load; 5-reading average |
| VO₂max (field or lab) | Every 6-12 months | Longitudinal fitness tracking |
| Lipid panel (ApoB, LDL-C, HDL-C, TG) | Annually | Atherosclerosis risk |
| hs-CRP | Annually | Vascular inflammation |
| Fasting glucose / HbA1c | Annually | Glycemic risk |
| CAC score | At 40-45; repeat if CAC=0 at 5-10 years | Actual coronary disease burden |
| PWV / vascular age | At specialized sports medicine lab | Arterial compliance; research standard |
Further reading¶
- Mandsager et al. 2018 (JAMA Network Open) — VO₂max and all-cause mortality (n=122k)
- Helgerud et al. 2007 (Medicine & Science in Sports) — 4×4 HIIT vs. Zone 2 for VO₂max
- Krauss 2010 (Current Atherosclerosis Reports) — LDL particle number vs. LDL-C
- PREDIMED Investigators 2013 (NEJM) — Mediterranean diet and CV events
- Blankstein et al. — CAC scoring in clinical decision-making
- SPORT-AND-MOVEMENT — training protocol depth
- SUPPLEMENTS — omega-3, K2, CoQ10 cardiovascular stack
- HEALTH-AS-INFRASTRUCTURE — cardiovascular in the four-lever model
References¶
- Mandsager, K. et al. (2018). Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Network Open. Primary source for the VO₂max–mortality dose-response curve.
- Helgerud, J. et al. (2007). Aerobic high-intensity intervals improve VO₂max more than moderate training. Medicine & Science in Sports & Exercise. Grounds the HIIT protocol recommendations.
- Krauss, R. (2010). Lipoprotein subfractions and cardiovascular disease risk. Current Atherosclerosis Reports. Source for the LDL particle number vs. LDL-C distinction.
- PREDIMED Investigators (2013). Primary prevention of cardiovascular disease with a Mediterranean diet. NEJM. RCT evidence for dietary cardiovascular protection.